Market Cap (In KRW)
285.93 Billion
Revenue (In KRW)
170.35 Billion
Net Income (In KRW)
36.72 Billion
Avg. Volume
27.54 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 20700.0-30700.0
- PE
- -
- EPS
- -
- Beta Value
- 0.68683
- ISIN
- KR7041830001
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Dr. Ki-Chul Cha
- Employee Count
- -
- Website
- https://www.inbody.com/global
- Ipo Date
- 2000-12-15
- Details
- InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in nephrology, liver disease, diabetes, nutrition, and rehabilitation applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.
More Stocks
-
3290
-
GPOVF
-
CARYSILCarysil Limited
CARYSIL
-
2705
-
FHN-PBFirst Horizon Corporation
FHN-PB
-
9193Tokyo Kisen Co.,Ltd.
9193
-
CNDF
-
3312GMI Technology Inc.
3312